This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oregon State University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Pasha Khan: Innovator in Immune Response Modulation
Introduction
Pasha Khan is a notable inventor based in New Delhi, India. He has made significant contributions to the field of immunology through his innovative research and patent work. His focus on immune response modulation has the potential to impact the treatment of autoimmune diseases.
Latest Patents
Pasha Khan holds a patent for "Aryl hydrocarbon receptor activators." This patent discloses small molecule AhR ligands that can induce the differentiation of Tr1 cells. These ligands are designed to suppress pathogenic immune responses without causing nonspecific immune suppression. Additionally, the patent outlines methods of treating autoimmune diseases using these AhR ligands.
Career Highlights
Pasha Khan is affiliated with Oregon State University, where he continues to advance his research in immunology. His work has garnered attention for its innovative approach to addressing complex immune system challenges.
Collaborations
Pasha collaborates with esteemed colleagues such as Siva Kumar Kolluri and Nancy I Kerkvliet. Their combined expertise enhances the research efforts in the field of immune response modulation.
Conclusion
Pasha Khan's contributions to immunology through his patent and research at Oregon State University highlight his role as an innovator in the field. His work has the potential to lead to significant advancements in the treatment of autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile